Denali Therapeutics
DNLI · NASDAQ
Bulios Fair Price
$13.97
31.8% downside
Trenutna cena
$20.47
Po podatkih Bulios Fair Price je delnica DNLI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Denali Therapeutics Inc. is a biotechnology company focused on developing therapeutics for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. The company specializes in discovering new drug candidates that can effectively cross the blood-brain barrier and target biological pathways associated with the progression of these diseases. Denali utilizes advanced technologies, including Blood-Brain Barrier Penetration, which allows for targeted delivery of drugs directly to the central nervous system, enhancing the efficacy of treatments.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Ryan J. Watts
Employees
503
Headquarters
South San Francisco
Prihajajoči dogodki
Earnings
Upcoming earnings report